Molecular Diagnostics
Combining Two Diagnostic Tests Drastically Reduces Cancer Miss Rates
The Papanicolaou (Pap) test is recommended for women between 21 and 65 years old as a screening test for cervical cancer. Women 30 and older who are negative on co-testing may wait as long as five years for their next testing, but physicians still recommend annual examinations. More...17 May 2016
CRISPR-based Technology Enables High-Resolution Zika Detection On Low-Cost Paper Discs
Building off their earlier innovative development in “programmable diagnostics”, researchers on an international, multi-institutional team recently joined efforts to quickly prototype their low-cost rapid test with the goal that it could soon be used to screen samples (blood, urine, or saliva) for Zika virus and strain identification. More...16 May 2016
Non-Invasive Prostate Cancer Test Developed Using Exosomal RNA
The current screening paradigm for prostate cancer faces challenges that lead to unnecessary biopsies and, ultimately, overtreatment. The disadvantage of Prostate-Specific Antigen (PSA) testing is lack of specificity for prostate cancer resulting in both false positive and false negative results. More...11 May 2016
Field-Applicable Molecular Test Diagnoses Tegumentary Leishmaniasis
Cutaneous and mucosal leishmaniases are widely distributed in Central and South America. Leishmania of the Viannia subgenus are the most frequent species infecting humans. L. (V.) braziliensis, L. (V.) panamensis are also responsible for metastatic mucosal leishmaniasis. More...11 May 2016
Bacterial Vaginosis Assessed By Molecular Methods
Bacterial vaginosis (BV) is an aberrant state of the vaginal microbiota, which is characterized by a depletion of lactobacilli, an increased diversity of the bacterial population and an elevated pH. It is one the most common vaginal syndromes in fertile, premenopausal and pregnant women. More...11 May 2016
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
Clinical Chemistry System
P780
In Other News
Novel Multiplexed Digital Immunohistochemistry Used On Tissue Sections
New Strategy Broadens Detection of Breast & Ovarian Cancer Gene Variants
Liver Cancer May Be Diagnosed from Altered Sugar Metabolism
Genetic Test Reduces Post-Surgery Chemotherapy for Breast Cancer Patients
Noninvasive Test Detects Colorectal Cancer in Unscreened Patients
Patterns of MicroRNA Expression Distinguish Patients with Asthma and Allergic Rhinitis
Genetic Link Confirmed Between DCIS And Invasive Disease
DNA-Based Test Determines Degree Of Liver Fibrosis
Genomics Makeup of Colorectal Tumors Predicts Immune Response
Pathway Implicated in Development of Eosinophilic Esophagitis
Blood Test Detects Genetic Mutations in Lung Cancer
Genetic Testing for Breast Cancer Patients Expanded
Blood Test Evaluated for Suspected Obstructive Coronary Artery Disease
Association Found Between MC1R Variant and Melanoma Risk
Prostate Needle Biopsy Biomarker Predicts Tumor Aggressiveness
Gene Test Identifies Patients with High Risk Colon Cancer
Improved “Liquid Biopsy” Technique Enhances Tumor DNA Detection
Establishment of Biomarker Panel May Lead to Rapid Tests for Early Diagnosis of Pancreatic Cancer
Genomic Sequencing Identifies Deadly Bloodstream Infection
Noncoding RNA Gene Linked to Malignant Melanoma
Novel Blood Test Detects Colorectal Cancer Recurrence Earlier
Hereditary Cancer Test Identifies Deleterious Mutations in Endometrial Cancer
Multigene Test Identifies Early Breast Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
